Atlas Trials

Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status

Clinical trial NCT00733616 · COMPLETED

Trial details

NCT number
NCT00733616
Sponsor
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2008-11-01
Primary completion
2012-05-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.